Ainos (AIMD), launched its first commercial AI Nose module optimized for industrial and healthcare settings, marking a pivotal milestone in the global commercialization of AI-powered digital olfaction. Built on the Company’s globally patented architecture, AI Nose combines advanced multi-sensor arrays with a proprietary smell language model to enable machines to detect, analyze, and quantify scents with human-like precision. The launch signals a new era in machine perception beyond visual, audio and text. Ainos engineers AI Nose to be portable and cloud-connected, optimized for seamless, scalable deployment into semiconductor fabrication, smart manufacturing, hospital infection control, and environmental monitoring, where scent detection is mission-critical. The SmellTech-as-a-Service subscription model ensures customers continue to receive software upgrades, cloud-based AI model enhancements, and tailored data analytics, ensuring clients stay at the cutting edge of scent intelligence.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AIMD: